{
  "ptid_time": "005_S_0223_2006-02-28",
  "img_path": "/data/qiuhui/data/adni/images/005_S_0223/2006-02-28/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 34,337 mm³, 22.3% above the reference mean. With a Z-score of 0.51 (69.5th percentile), this represents normal volume ; hippocampal volume measures 5,565 mm³, 21.8% below the reference mean. With a Z-score of -2.00 (2.3th percentile), this represents moderate atrophy; whole brain volume measures 964,368 mm³, 1.1% below the reference mean. With a Z-score of -0.13 (44.7th percentile), this represents normal volume ; entorhinal cortex volume measures 1,870 mm³, 49.1% below the reference mean. With a Z-score of -3.01 (0.1th percentile), this represents profound atrophy; fusiform gyrus volume measures 14,024 mm³, 17.6% below the reference mean. With a Z-score of -1.60 (5.5th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 16,884 mm³, 11.9% below the reference mean. With a Z-score of -1.03 (15.0th percentile), this represents mild atrophy. ",
  "text_data": "Age is 78.0 years. Gender is Female. Education: 18 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Smoking; Major Surgical Procedures. MMSE: 30.0. Logical Memory: 19.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 751.50 pg/mL (normal ); Total tau: 382.80 pg/mL (moderate elevated); Phosphorylated tau: 41.03 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus, entorhinal cortex, fusiform gyrus, and middle temporal gyrus—key regions affected in Alzheimer’s disease (AD). Despite normal Aβ levels, elevated T-tau and P-tau suggest neurodegeneration. The preserved MMSE score (30/30) may indicate early-stage disease or cognitive reserve masking deficits.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology, given biomarker and atrophy patterns).  \n\n**Confidence:** **Medium** (MMSE is normal, but structural and CSF biomarkers strongly suggest underlying AD pathology; clinical follow-up needed to assess symptom progression).  \n\n---  \n*Note:* If longitudinal data reveals cognitive decline, this would upgrade to \"Dementia due to AD.\" Current tau elevation with normal Aβ is atypical for AD but may reflect non-AD tauopathy or a \"suspected non-Alzheimer pathophysiology\" (SNAP) profile.",
  "timestamp": "2025-07-25T21:03:37.471024"
}